Diamond Power Infrastructure Limited (DIACABS.NS) Stock Competitors & Peer Comparison
See (DIACABS.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DIACABS.NS | ₹203.60 | +7.91% | 101.5B | 64.23 | ₹3.00 | N/A |
| CUMMINSIND.BO | ₹5,784.15 | +1.70% | 1.6T | 71.38 | ₹81.08 | +0.92% |
| CUMMINSIND.NS | ₹5,784.00 | +1.61% | 1.6T | 68.05 | ₹85.05 | +0.92% |
| ABB.BO | ₹7,163.65 | -0.30% | 1.5T | 85.87 | ₹83.38 | +0.55% |
| ABB.NS | ₹7,167.50 | -0.40% | 1.5T | 97.23 | ₹73.60 | +0.55% |
| BHEL.BO | ₹387.00 | -4.70% | 1.4T | 84.75 | ₹4.60 | +0.13% |
| BHEL.NS | ₹386.95 | -4.76% | 1.4T | 84.61 | ₹4.60 | +0.13% |
| SIEMENS.NS | ₹3,700.80 | -0.24% | 1.3T | 77.62 | ₹47.50 | N/A |
| SIEMENS.BO | ₹3,701.90 | -0.19% | 1.3T | 77.82 | ₹47.37 | N/A |
| THERMAX.NS | ₹4,832.10 | +0.99% | 549.3B | 76.06 | ₹64.11 | +0.29% |
Stock Comparison
DIACABS.NS vs CUMMINSIND.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, CUMMINSIND.BO has a market cap of 1.6T. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while CUMMINSIND.BO trades at ₹5,784.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas CUMMINSIND.BO's P/E ratio is 71.38. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to CUMMINSIND.BO's ROE of +0.30%. Regarding short-term risk, DIACABS.NS is more volatile compared to CUMMINSIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check CUMMINSIND.BO's competition here
DIACABS.NS vs CUMMINSIND.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, CUMMINSIND.NS has a market cap of 1.6T. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while CUMMINSIND.NS trades at ₹5,784.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas CUMMINSIND.NS's P/E ratio is 68.05. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to CUMMINSIND.NS's ROE of +0.30%. Regarding short-term risk, DIACABS.NS is more volatile compared to CUMMINSIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check CUMMINSIND.NS's competition here
DIACABS.NS vs ABB.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ABB.BO has a market cap of 1.5T. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ABB.BO trades at ₹7,163.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ABB.BO's P/E ratio is 85.87. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ABB.BO's ROE of +0.41%. Regarding short-term risk, DIACABS.NS is more volatile compared to ABB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ABB.BO's competition here
DIACABS.NS vs ABB.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ABB.NS has a market cap of 1.5T. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ABB.NS trades at ₹7,167.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ABB.NS's P/E ratio is 97.23. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ABB.NS's ROE of +0.41%. Regarding short-term risk, DIACABS.NS is more volatile compared to ABB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ABB.NS's competition here
DIACABS.NS vs BHEL.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, BHEL.BO has a market cap of 1.4T. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while BHEL.BO trades at ₹387.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas BHEL.BO's P/E ratio is 84.75. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to BHEL.BO's ROE of +0.06%. Regarding short-term risk, DIACABS.NS is more volatile compared to BHEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check BHEL.BO's competition here
DIACABS.NS vs BHEL.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, BHEL.NS has a market cap of 1.4T. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while BHEL.NS trades at ₹386.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas BHEL.NS's P/E ratio is 84.61. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to BHEL.NS's ROE of +0.06%. Regarding short-term risk, DIACABS.NS is more volatile compared to BHEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check BHEL.NS's competition here
DIACABS.NS vs SIEMENS.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, SIEMENS.NS has a market cap of 1.3T. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while SIEMENS.NS trades at ₹3,700.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas SIEMENS.NS's P/E ratio is 77.62. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to SIEMENS.NS's ROE of +0.12%. Regarding short-term risk, DIACABS.NS is more volatile compared to SIEMENS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SIEMENS.NS's competition here
DIACABS.NS vs SIEMENS.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, SIEMENS.BO has a market cap of 1.3T. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while SIEMENS.BO trades at ₹3,701.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas SIEMENS.BO's P/E ratio is 77.82. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to SIEMENS.BO's ROE of +0.12%. Regarding short-term risk, DIACABS.NS is more volatile compared to SIEMENS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SIEMENS.BO's competition here
DIACABS.NS vs THERMAX.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, THERMAX.NS has a market cap of 549.3B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while THERMAX.NS trades at ₹4,832.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas THERMAX.NS's P/E ratio is 76.06. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to THERMAX.NS's ROE of +0.14%. Regarding short-term risk, DIACABS.NS is more volatile compared to THERMAX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check THERMAX.NS's competition here
DIACABS.NS vs THERMAX.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, THERMAX.BO has a market cap of 548.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while THERMAX.BO trades at ₹4,832.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas THERMAX.BO's P/E ratio is 80.64. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to THERMAX.BO's ROE of +0.14%. Regarding short-term risk, DIACABS.NS is more volatile compared to THERMAX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check THERMAX.BO's competition here
DIACABS.NS vs AIAENG.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, AIAENG.NS has a market cap of 428.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while AIAENG.NS trades at ₹4,630.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas AIAENG.NS's P/E ratio is 33.77. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to AIAENG.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to AIAENG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check AIAENG.NS's competition here
DIACABS.NS vs AIAENG.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, AIAENG.BO has a market cap of 428.4B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while AIAENG.BO trades at ₹4,631.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas AIAENG.BO's P/E ratio is 36.83. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to AIAENG.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to AIAENG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check AIAENG.BO's competition here
DIACABS.NS vs VOLTAS.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, VOLTAS.NS has a market cap of 425.7B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while VOLTAS.NS trades at ₹1,298.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas VOLTAS.NS's P/E ratio is 113.85. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to VOLTAS.NS's ROE of +0.06%. Regarding short-term risk, DIACABS.NS is more volatile compared to VOLTAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check VOLTAS.NS's competition here
DIACABS.NS vs VOLTAS.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, VOLTAS.BO has a market cap of 425.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while VOLTAS.BO trades at ₹1,297.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas VOLTAS.BO's P/E ratio is 84.61. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to VOLTAS.BO's ROE of +0.06%. Regarding short-term risk, DIACABS.NS is more volatile compared to VOLTAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check VOLTAS.BO's competition here
DIACABS.NS vs GET&D.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, GET&D.NS has a market cap of 397.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while GET&D.NS trades at ₹1,552.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas GET&D.NS's P/E ratio is 100.73. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to GET&D.NS's ROE of +0.27%. Regarding short-term risk, DIACABS.NS is more volatile compared to GET&D.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GET&D.NS's competition here
DIACABS.NS vs BLUESTARCO.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, BLUESTARCO.NS has a market cap of 330.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while BLUESTARCO.NS trades at ₹1,581.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas BLUESTARCO.NS's P/E ratio is 62.82. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to BLUESTARCO.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to BLUESTARCO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check BLUESTARCO.NS's competition here
DIACABS.NS vs BLUESTARCO.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, BLUESTARCO.BO has a market cap of 330.2B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while BLUESTARCO.BO trades at ₹1,582.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas BLUESTARCO.BO's P/E ratio is 66.75. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to BLUESTARCO.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to BLUESTARCO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check BLUESTARCO.BO's competition here
DIACABS.NS vs KIRLOSENG.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KIRLOSENG.BO has a market cap of 283.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KIRLOSENG.BO trades at ₹1,911.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KIRLOSENG.BO's P/E ratio is 49.91. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KIRLOSENG.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLOSENG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLOSENG.BO's competition here
DIACABS.NS vs KIRLOSENG.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KIRLOSENG.NS has a market cap of 283.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KIRLOSENG.NS trades at ₹1,913.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KIRLOSENG.NS's P/E ratio is 50.01. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KIRLOSENG.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLOSENG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLOSENG.NS's competition here
DIACABS.NS vs MTARTECH.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, MTARTECH.BO has a market cap of 238.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while MTARTECH.BO trades at ₹7,540.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas MTARTECH.BO's P/E ratio is 256.07. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to MTARTECH.BO's ROE of +0.12%. Regarding short-term risk, DIACABS.NS is more volatile compared to MTARTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check MTARTECH.BO's competition here
DIACABS.NS vs MTARTECH.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, MTARTECH.NS has a market cap of 238.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while MTARTECH.NS trades at ₹7,535.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas MTARTECH.NS's P/E ratio is 255.87. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to MTARTECH.NS's ROE of +0.12%. Regarding short-term risk, DIACABS.NS is more volatile compared to MTARTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check MTARTECH.NS's competition here
DIACABS.NS vs TRITURBINE.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, TRITURBINE.NS has a market cap of 220.4B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while TRITURBINE.NS trades at ₹686.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas TRITURBINE.NS's P/E ratio is 63.21. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to TRITURBINE.NS's ROE of +0.27%. Regarding short-term risk, DIACABS.NS is more volatile compared to TRITURBINE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TRITURBINE.NS's competition here
DIACABS.NS vs TRITURBINE.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, TRITURBINE.BO has a market cap of 220.4B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while TRITURBINE.BO trades at ₹687.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas TRITURBINE.BO's P/E ratio is 62.86. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to TRITURBINE.BO's ROE of +0.27%. Regarding short-term risk, DIACABS.NS is more volatile compared to TRITURBINE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TRITURBINE.BO's competition here
DIACABS.NS vs KAYNES.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KAYNES.BO has a market cap of 213.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KAYNES.BO trades at ₹3,122.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KAYNES.BO's P/E ratio is 58.49. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KAYNES.BO's ROE of +0.10%. Regarding short-term risk, DIACABS.NS is more volatile compared to KAYNES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KAYNES.BO's competition here
DIACABS.NS vs KAYNES.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KAYNES.NS has a market cap of 213.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KAYNES.NS trades at ₹3,121.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KAYNES.NS's P/E ratio is 58.74. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KAYNES.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.NS is more volatile compared to KAYNES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KAYNES.NS's competition here
DIACABS.NS vs TDPOWERSYS.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, TDPOWERSYS.NS has a market cap of 207.1B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while TDPOWERSYS.NS trades at ₹1,312.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas TDPOWERSYS.NS's P/E ratio is 86.58. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to TDPOWERSYS.NS's ROE of +0.25%. Regarding short-term risk, DIACABS.NS is more volatile compared to TDPOWERSYS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TDPOWERSYS.NS's competition here
DIACABS.NS vs TDPOWERSYS.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, TDPOWERSYS.BO has a market cap of 207B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while TDPOWERSYS.BO trades at ₹1,312.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas TDPOWERSYS.BO's P/E ratio is 86.51. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to TDPOWERSYS.BO's ROE of +0.25%. Regarding short-term risk, DIACABS.NS is more volatile compared to TDPOWERSYS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TDPOWERSYS.BO's competition here
DIACABS.NS vs ELGIEQUIP.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ELGIEQUIP.BO has a market cap of 196.2B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ELGIEQUIP.BO trades at ₹609.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ELGIEQUIP.BO's P/E ratio is 45.67. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ELGIEQUIP.BO's ROE of +0.22%. Regarding short-term risk, DIACABS.NS is more volatile compared to ELGIEQUIP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ELGIEQUIP.BO's competition here
DIACABS.NS vs ELGIEQUIP.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ELGIEQUIP.NS has a market cap of 196.1B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ELGIEQUIP.NS trades at ₹610.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ELGIEQUIP.NS's P/E ratio is 45.71. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ELGIEQUIP.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.NS is more volatile compared to ELGIEQUIP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ELGIEQUIP.NS's competition here
DIACABS.NS vs LAXMIMACH.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, LAXMIMACH.BO has a market cap of 185.2B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while LAXMIMACH.BO trades at ₹17,338.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas LAXMIMACH.BO's P/E ratio is 63.86. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to LAXMIMACH.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.NS is more volatile compared to LAXMIMACH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LAXMIMACH.BO's competition here
DIACABS.NS vs LAXMIMACH.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, LAXMIMACH.NS has a market cap of 185.1B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while LAXMIMACH.NS trades at ₹17,324.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas LAXMIMACH.NS's P/E ratio is 63.45. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to LAXMIMACH.NS's ROE of +0.15%. Regarding short-term risk, DIACABS.NS is more volatile compared to LAXMIMACH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LAXMIMACH.NS's competition here
DIACABS.NS vs LMW.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, LMW.NS has a market cap of 168.8B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while LMW.NS trades at ₹15,679.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas LMW.NS's P/E ratio is 129.51. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to LMW.NS's ROE of +0.05%. Regarding short-term risk, DIACABS.NS is more volatile compared to LMW.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LMW.NS's competition here
DIACABS.NS vs LMW.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, LMW.BO has a market cap of 168.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while LMW.BO trades at ₹15,646.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas LMW.BO's P/E ratio is 128.65. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to LMW.BO's ROE of +0.15%. Regarding short-term risk, DIACABS.NS is more volatile compared to LMW.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LMW.BO's competition here
DIACABS.NS vs AZAD.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, AZAD.NS has a market cap of 142.1B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while AZAD.NS trades at ₹2,207.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas AZAD.NS's P/E ratio is 107.39. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to AZAD.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is more volatile compared to AZAD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check AZAD.NS's competition here
DIACABS.NS vs TEGA.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, TEGA.NS has a market cap of 140.7B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while TEGA.NS trades at ₹1,847.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas TEGA.NS's P/E ratio is 91.51. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to TEGA.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.NS is more volatile compared to TEGA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TEGA.NS's competition here
DIACABS.NS vs TEGA.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, TEGA.BO has a market cap of 140.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while TEGA.BO trades at ₹1,846.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas TEGA.BO's P/E ratio is 91.49. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to TEGA.BO's ROE of +0.07%. Regarding short-term risk, DIACABS.NS is more volatile compared to TEGA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TEGA.BO's competition here
DIACABS.NS vs KSB.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KSB.NS has a market cap of 138.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KSB.NS trades at ₹814.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KSB.NS's P/E ratio is 53.57. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KSB.NS's ROE of +0.16%. Regarding short-term risk, DIACABS.NS is more volatile compared to KSB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KSB.NS's competition here
DIACABS.NS vs KSB.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KSB.BO has a market cap of 138B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KSB.BO trades at ₹813.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KSB.BO's P/E ratio is 53.31. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KSB.BO's ROE of +0.16%. Regarding short-term risk, DIACABS.NS is more volatile compared to KSB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KSB.BO's competition here
DIACABS.NS vs INOXINDIA.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, INOXINDIA.NS has a market cap of 136.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while INOXINDIA.NS trades at ₹1,578.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas INOXINDIA.NS's P/E ratio is 53.14. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to INOXINDIA.NS's ROE of +0.27%. Regarding short-term risk, DIACABS.NS is more volatile compared to INOXINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check INOXINDIA.NS's competition here
DIACABS.NS vs JYOTICNC.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, JYOTICNC.NS has a market cap of 136B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while JYOTICNC.NS trades at ₹634.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas JYOTICNC.NS's P/E ratio is 40.51. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to JYOTICNC.NS's ROE of +0.19%. Regarding short-term risk, DIACABS.NS is more volatile compared to JYOTICNC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check JYOTICNC.NS's competition here
DIACABS.NS vs KIRLOSBROS.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KIRLOSBROS.NS has a market cap of 129B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KIRLOSBROS.NS trades at ₹1,711.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KIRLOSBROS.NS's P/E ratio is 34.58. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KIRLOSBROS.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLOSBROS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLOSBROS.NS's competition here
DIACABS.NS vs KIRLOSBROS.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KIRLOSBROS.BO has a market cap of 128.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KIRLOSBROS.BO trades at ₹1,712.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KIRLOSBROS.BO's P/E ratio is 32.84. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KIRLOSBROS.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLOSBROS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLOSBROS.BO's competition here
DIACABS.NS vs INGERRAND.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, INGERRAND.BO has a market cap of 121.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while INGERRAND.BO trades at ₹3,962.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas INGERRAND.BO's P/E ratio is 46.11. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to INGERRAND.BO's ROE of +0.41%. Regarding short-term risk, DIACABS.NS is more volatile compared to INGERRAND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check INGERRAND.BO's competition here
DIACABS.NS vs INGERRAND.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, INGERRAND.NS has a market cap of 121.7B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while INGERRAND.NS trades at ₹3,960.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas INGERRAND.NS's P/E ratio is 47.43. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to INGERRAND.NS's ROE of +0.41%. Regarding short-term risk, DIACABS.NS is more volatile compared to INGERRAND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check INGERRAND.NS's competition here
DIACABS.NS vs ELECON.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ELECON.BO has a market cap of 113.8B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ELECON.BO trades at ₹531.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ELECON.BO's P/E ratio is 33.37. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ELECON.BO's ROE of +0.16%. Regarding short-term risk, DIACABS.NS is more volatile compared to ELECON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ELECON.BO's competition here
DIACABS.NS vs ELECON.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ELECON.NS has a market cap of 113.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ELECON.NS trades at ₹531.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ELECON.NS's P/E ratio is 33.28. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ELECON.NS's ROE of +0.16%. Regarding short-term risk, DIACABS.NS is more volatile compared to ELECON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ELECON.NS's competition here
DIACABS.NS vs KIRLPNU.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KIRLPNU.BO has a market cap of 103.8B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KIRLPNU.BO trades at ₹1,566.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KIRLPNU.BO's P/E ratio is 40.51. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KIRLPNU.BO's ROE of +0.22%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLPNU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLPNU.BO's competition here
DIACABS.NS vs KIRLPNU.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KIRLPNU.NS has a market cap of 103.8B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KIRLPNU.NS trades at ₹1,570.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KIRLPNU.NS's P/E ratio is 40.50. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KIRLPNU.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.NS is more volatile compared to KIRLPNU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KIRLPNU.NS's competition here
DIACABS.NS vs DIACABS.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, DIACABS.BO has a market cap of 101.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while DIACABS.BO trades at ₹203.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas DIACABS.BO's P/E ratio is 64.25. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to DIACABS.BO's ROE of -0.21%. Regarding short-term risk, DIACABS.NS is more volatile compared to DIACABS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check DIACABS.BO's competition here
DIACABS.NS vs VESUVIUS.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, VESUVIUS.NS has a market cap of 96.7B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while VESUVIUS.NS trades at ₹473.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas VESUVIUS.NS's P/E ratio is 37.07. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to VESUVIUS.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to VESUVIUS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check VESUVIUS.NS's competition here
DIACABS.NS vs VESUVIUS.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, VESUVIUS.BO has a market cap of 96.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while VESUVIUS.BO trades at ₹472.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas VESUVIUS.BO's P/E ratio is 37.01. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to VESUVIUS.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to VESUVIUS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check VESUVIUS.BO's competition here
DIACABS.NS vs LLOYDSENGG.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, LLOYDSENGG.NS has a market cap of 96.1B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while LLOYDSENGG.NS trades at ₹72.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas LLOYDSENGG.NS's P/E ratio is 47.99. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to LLOYDSENGG.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to LLOYDSENGG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LLOYDSENGG.NS's competition here
DIACABS.NS vs LLOYDSENGG.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, LLOYDSENGG.BO has a market cap of 95.8B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while LLOYDSENGG.BO trades at ₹72.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas LLOYDSENGG.BO's P/E ratio is 47.85. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to LLOYDSENGG.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to LLOYDSENGG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LLOYDSENGG.BO's competition here
DIACABS.NS vs ISGEC.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ISGEC.BO has a market cap of 67.7B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ISGEC.BO trades at ₹928.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ISGEC.BO's P/E ratio is 62.06. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ISGEC.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is more volatile compared to ISGEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ISGEC.BO's competition here
DIACABS.NS vs ISGEC.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ISGEC.NS has a market cap of 67.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ISGEC.NS trades at ₹928.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ISGEC.NS's P/E ratio is 61.96. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ISGEC.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is more volatile compared to ISGEC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ISGEC.NS's competition here
DIACABS.NS vs SHAKTIPUMP.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, SHAKTIPUMP.NS has a market cap of 65.7B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while SHAKTIPUMP.NS trades at ₹540.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas SHAKTIPUMP.NS's P/E ratio is 25.34. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to SHAKTIPUMP.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to SHAKTIPUMP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SHAKTIPUMP.NS's competition here
DIACABS.NS vs SHAKTIPUMP.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, SHAKTIPUMP.BO has a market cap of 65.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while SHAKTIPUMP.BO trades at ₹540.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas SHAKTIPUMP.BO's P/E ratio is 25.35. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to SHAKTIPUMP.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to SHAKTIPUMP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SHAKTIPUMP.BO's competition here
DIACABS.NS vs DIAPOWER.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, DIAPOWER.NS has a market cap of 52.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while DIAPOWER.NS trades at ₹195.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas DIAPOWER.NS's P/E ratio is -1.78. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to DIAPOWER.NS's ROE of +0.05%. Regarding short-term risk, DIACABS.NS is less volatile compared to DIAPOWER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check DIAPOWER.NS's competition here
DIACABS.NS vs LSIL.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, LSIL.NS has a market cap of 52.1B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while LSIL.NS trades at ₹48.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas LSIL.NS's P/E ratio is 130.41. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to LSIL.NS's ROE of +0.22%. Regarding short-term risk, DIACABS.NS is more volatile compared to LSIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LSIL.NS's competition here
DIACABS.NS vs TEXRAIL.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, TEXRAIL.BO has a market cap of 42.7B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while TEXRAIL.BO trades at ₹104.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas TEXRAIL.BO's P/E ratio is 21.67. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to TEXRAIL.BO's ROE of +0.07%. Regarding short-term risk, DIACABS.NS is more volatile compared to TEXRAIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TEXRAIL.BO's competition here
DIACABS.NS vs TEXRAIL.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, TEXRAIL.NS has a market cap of 42.7B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while TEXRAIL.NS trades at ₹104.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas TEXRAIL.NS's P/E ratio is 21.67. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to TEXRAIL.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.NS is more volatile compared to TEXRAIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check TEXRAIL.NS's competition here
DIACABS.NS vs GREAVESCOT.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, GREAVESCOT.NS has a market cap of 42.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while GREAVESCOT.NS trades at ₹192.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas GREAVESCOT.NS's P/E ratio is 40.13. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to GREAVESCOT.NS's ROE of +0.07%. Regarding short-term risk, DIACABS.NS is more volatile compared to GREAVESCOT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GREAVESCOT.NS's competition here
DIACABS.NS vs GREAVESCOT.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, GREAVESCOT.BO has a market cap of 42.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while GREAVESCOT.BO trades at ₹192.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas GREAVESCOT.BO's P/E ratio is 41.08. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to GREAVESCOT.BO's ROE of +0.07%. Regarding short-term risk, DIACABS.NS is more volatile compared to GREAVESCOT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GREAVESCOT.BO's competition here
DIACABS.NS vs WPIL.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, WPIL.BO has a market cap of 41.3B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while WPIL.BO trades at ₹421.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas WPIL.BO's P/E ratio is 26.17. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to WPIL.BO's ROE of +0.10%. Regarding short-term risk, DIACABS.NS is more volatile compared to WPIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check WPIL.BO's competition here
DIACABS.NS vs ANUP.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ANUP.BO has a market cap of 38.4B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ANUP.BO trades at ₹1,911.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ANUP.BO's P/E ratio is 34.89. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ANUP.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to ANUP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ANUP.BO's competition here
DIACABS.NS vs ANUP.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ANUP.NS has a market cap of 38.3B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ANUP.NS trades at ₹1,915.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ANUP.NS's P/E ratio is 34.73. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ANUP.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to ANUP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ANUP.NS's competition here
DIACABS.NS vs GMMPFAUDLR.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, GMMPFAUDLR.NS has a market cap of 35.1B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while GMMPFAUDLR.NS trades at ₹788.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas GMMPFAUDLR.NS's P/E ratio is 60.64. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to GMMPFAUDLR.NS's ROE of +0.06%. Regarding short-term risk, DIACABS.NS is more volatile compared to GMMPFAUDLR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GMMPFAUDLR.NS's competition here
DIACABS.NS vs GMMPFAUDLR.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, GMMPFAUDLR.BO has a market cap of 35.1B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while GMMPFAUDLR.BO trades at ₹786.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas GMMPFAUDLR.BO's P/E ratio is 60.65. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to GMMPFAUDLR.BO's ROE of -0.02%. Regarding short-term risk, DIACABS.NS is more volatile compared to GMMPFAUDLR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GMMPFAUDLR.BO's competition here
DIACABS.NS vs SHANTIGEAR.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, SHANTIGEAR.NS has a market cap of 33.8B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while SHANTIGEAR.NS trades at ₹441.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas SHANTIGEAR.NS's P/E ratio is 44.14. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to SHANTIGEAR.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to SHANTIGEAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SHANTIGEAR.NS's competition here
DIACABS.NS vs SHANTIGEAR.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, SHANTIGEAR.BO has a market cap of 33.8B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while SHANTIGEAR.BO trades at ₹443.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas SHANTIGEAR.BO's P/E ratio is 44.18. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to SHANTIGEAR.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to SHANTIGEAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SHANTIGEAR.BO's competition here
DIACABS.NS vs SETL.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, SETL.NS has a market cap of 27.4B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while SETL.NS trades at ₹154.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas SETL.NS's P/E ratio is 34.26. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to SETL.NS's ROE of +0.08%. Regarding short-term risk, DIACABS.NS is less volatile compared to SETL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check SETL.NS's competition here
DIACABS.NS vs SGLTL.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, SGLTL.NS has a market cap of 27.4B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while SGLTL.NS trades at ₹137.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas SGLTL.NS's P/E ratio is 38.46. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to SGLTL.NS's ROE of +0.10%. Regarding short-term risk, DIACABS.NS is more volatile compared to SGLTL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check SGLTL.NS's competition here
DIACABS.NS vs HLEGLAS.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, HLEGLAS.BO has a market cap of 26.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while HLEGLAS.BO trades at ₹385.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas HLEGLAS.BO's P/E ratio is 53.75. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to HLEGLAS.BO's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is more volatile compared to HLEGLAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check HLEGLAS.BO's competition here
DIACABS.NS vs HLEGLAS.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, HLEGLAS.NS has a market cap of 26.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while HLEGLAS.NS trades at ₹384.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas HLEGLAS.NS's P/E ratio is 53.75. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to HLEGLAS.NS's ROE of +0.09%. Regarding short-term risk, DIACABS.NS is more volatile compared to HLEGLAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check HLEGLAS.NS's competition here
DIACABS.NS vs JASH.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, JASH.NS has a market cap of 26.8B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while JASH.NS trades at ₹448.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas JASH.NS's P/E ratio is 35.54. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to JASH.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to JASH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check JASH.NS's competition here
DIACABS.NS vs WINDMACHIN.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, WINDMACHIN.BO has a market cap of 25.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while WINDMACHIN.BO trades at ₹285.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas WINDMACHIN.BO's P/E ratio is 3545.62. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to WINDMACHIN.BO's ROE of -0.00%. Regarding short-term risk, DIACABS.NS is more volatile compared to WINDMACHIN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check WINDMACHIN.BO's competition here
DIACABS.NS vs WINDMACHIN.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, WINDMACHIN.NS has a market cap of 25.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while WINDMACHIN.NS trades at ₹285.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas WINDMACHIN.NS's P/E ratio is 3545.62. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to WINDMACHIN.NS's ROE of -0.00%. Regarding short-term risk, DIACABS.NS is more volatile compared to WINDMACHIN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check WINDMACHIN.NS's competition here
DIACABS.NS vs KLBRENG-B.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KLBRENG-B.BO has a market cap of 25.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KLBRENG-B.BO trades at ₹486.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KLBRENG-B.BO's P/E ratio is 25.70. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KLBRENG-B.BO's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to KLBRENG-B.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KLBRENG-B.BO's competition here
DIACABS.NS vs ADVAIT.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ADVAIT.BO has a market cap of 24.2B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ADVAIT.BO trades at ₹2,179.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ADVAIT.BO's P/E ratio is 46.81. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ADVAIT.BO's ROE of +0.23%. Regarding short-term risk, DIACABS.NS is more volatile compared to ADVAIT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ADVAIT.BO's competition here
DIACABS.NS vs HONDAPOWER.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, HONDAPOWER.NS has a market cap of 23.7B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while HONDAPOWER.NS trades at ₹2,291.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas HONDAPOWER.NS's P/E ratio is 36.80. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to HONDAPOWER.NS's ROE of +0.08%. Regarding short-term risk, DIACABS.NS is more volatile compared to HONDAPOWER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check HONDAPOWER.NS's competition here
DIACABS.NS vs HONDAPOWER.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, HONDAPOWER.BO has a market cap of 23.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while HONDAPOWER.BO trades at ₹2,283.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas HONDAPOWER.BO's P/E ratio is 36.85. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to HONDAPOWER.BO's ROE of +0.08%. Regarding short-term risk, DIACABS.NS is more volatile compared to HONDAPOWER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check HONDAPOWER.BO's competition here
DIACABS.NS vs JNKINDIA.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, JNKINDIA.NS has a market cap of 23.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while JNKINDIA.NS trades at ₹421.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas JNKINDIA.NS's P/E ratio is 36.47. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to JNKINDIA.NS's ROE of +0.12%. Regarding short-term risk, DIACABS.NS is more volatile compared to JNKINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check JNKINDIA.NS's competition here
DIACABS.NS vs KMEW.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, KMEW.BO has a market cap of 23.4B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while KMEW.BO trades at ₹1,841.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas KMEW.BO's P/E ratio is 55.36. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to KMEW.BO's ROE of +0.25%. Regarding short-term risk, DIACABS.NS is more volatile compared to KMEW.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check KMEW.BO's competition here
DIACABS.NS vs GMM.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, GMM.BO has a market cap of 22.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while GMM.BO trades at ₹1,563.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas GMM.BO's P/E ratio is 31.46. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to GMM.BO's ROE of -0.02%. Regarding short-term risk, DIACABS.NS is more volatile compared to GMM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check GMM.BO's competition here
DIACABS.NS vs NIBE.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, NIBE.BO has a market cap of 22.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while NIBE.BO trades at ₹1,594.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas NIBE.BO's P/E ratio is 443.55. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to NIBE.BO's ROE of +0.02%. Regarding short-term risk, DIACABS.NS is less volatile compared to NIBE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check NIBE.BO's competition here
DIACABS.NS vs NIBE.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, NIBE.NS has a market cap of 22.4B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while NIBE.NS trades at ₹1,590.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas NIBE.NS's P/E ratio is 455.03. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to NIBE.NS's ROE of +0.02%. Regarding short-term risk, DIACABS.NS is less volatile compared to NIBE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for DIACABS.NS.Check NIBE.NS's competition here
DIACABS.NS vs PIXTRANS.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, PIXTRANS.NS has a market cap of 21.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while PIXTRANS.NS trades at ₹1,608.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas PIXTRANS.NS's P/E ratio is 20.04. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to PIXTRANS.NS's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to PIXTRANS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check PIXTRANS.NS's competition here
DIACABS.NS vs PIXTRANS.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, PIXTRANS.BO has a market cap of 21.9B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while PIXTRANS.BO trades at ₹1,602.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas PIXTRANS.BO's P/E ratio is 20.00. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to PIXTRANS.BO's ROE of +0.17%. Regarding short-term risk, DIACABS.NS is more volatile compared to PIXTRANS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check PIXTRANS.BO's competition here
DIACABS.NS vs PENIND.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, PENIND.NS has a market cap of 21.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while PENIND.NS trades at ₹158.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas PENIND.NS's P/E ratio is 15.56. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to PENIND.NS's ROE of +0.13%. Regarding short-term risk, DIACABS.NS is more volatile compared to PENIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check PENIND.NS's competition here
DIACABS.NS vs PENIND.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, PENIND.BO has a market cap of 21.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while PENIND.BO trades at ₹158.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas PENIND.BO's P/E ratio is 15.52. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to PENIND.BO's ROE of +0.13%. Regarding short-term risk, DIACABS.NS is more volatile compared to PENIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check PENIND.BO's competition here
DIACABS.NS vs ADOR.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ADOR.BO has a market cap of 19.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ADOR.BO trades at ₹1,127.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ADOR.BO's P/E ratio is 23.84. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ADOR.BO's ROE of +0.16%. Regarding short-term risk, DIACABS.NS is more volatile compared to ADOR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ADOR.BO's competition here
DIACABS.NS vs ADOR.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ADOR.NS has a market cap of 19.5B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ADOR.NS trades at ₹1,132.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ADOR.NS's P/E ratio is 23.82. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ADOR.NS's ROE of +0.16%. Regarding short-term risk, DIACABS.NS is more volatile compared to ADOR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ADOR.NS's competition here
DIACABS.NS vs THEJO.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, THEJO.NS has a market cap of 17B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while THEJO.NS trades at ₹1,545.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas THEJO.NS's P/E ratio is 34.45. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to THEJO.NS's ROE of +0.15%. Regarding short-term risk, DIACABS.NS is more volatile compared to THEJO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check THEJO.NS's competition here
DIACABS.NS vs LXMIATO.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, LXMIATO.BO has a market cap of 16.6B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while LXMIATO.BO trades at ₹2,483.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas LXMIATO.BO's P/E ratio is 584.15. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to LXMIATO.BO's ROE of +0.01%. Regarding short-term risk, DIACABS.NS is more volatile compared to LXMIATO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check LXMIATO.BO's competition here
DIACABS.NS vs JYOTISTRUC.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, JYOTISTRUC.NS has a market cap of 16.4B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while JYOTISTRUC.NS trades at ₹13.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas JYOTISTRUC.NS's P/E ratio is 29.17. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to JYOTISTRUC.NS's ROE of +0.11%. Regarding short-term risk, DIACABS.NS is more volatile compared to JYOTISTRUC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check JYOTISTRUC.NS's competition here
DIACABS.NS vs JYOTISTRUC.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, JYOTISTRUC.BO has a market cap of 16.4B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while JYOTISTRUC.BO trades at ₹13.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas JYOTISTRUC.BO's P/E ratio is 30.47. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to JYOTISTRUC.BO's ROE of +0.11%. Regarding short-term risk, DIACABS.NS is more volatile compared to JYOTISTRUC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check JYOTISTRUC.BO's competition here
DIACABS.NS vs DISAQ.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, DISAQ.BO has a market cap of 16.3B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while DISAQ.BO trades at ₹11,200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas DISAQ.BO's P/E ratio is 30.44. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to DISAQ.BO's ROE of +0.19%. Regarding short-term risk, DIACABS.NS is more volatile compared to DISAQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check DISAQ.BO's competition here
DIACABS.NS vs ADORWELD.NS Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ADORWELD.NS has a market cap of 14.8B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ADORWELD.NS trades at ₹852.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ADORWELD.NS's P/E ratio is 33.22. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ADORWELD.NS's ROE of +0.18%. Regarding short-term risk, DIACABS.NS is more volatile compared to ADORWELD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ADORWELD.NS's competition here
DIACABS.NS vs ADORWELD.BO Comparison June 2026
DIACABS.NS plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DIACABS.NS stands at 101.5B. In comparison, ADORWELD.BO has a market cap of 14.8B. Regarding current trading prices, DIACABS.NS is priced at ₹203.60, while ADORWELD.BO trades at ₹852.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DIACABS.NS currently has a P/E ratio of 64.23, whereas ADORWELD.BO's P/E ratio is 24.67. In terms of profitability, DIACABS.NS's ROE is -0.21%, compared to ADORWELD.BO's ROE of +0.02%. Regarding short-term risk, DIACABS.NS is more volatile compared to ADORWELD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for DIACABS.NS.Check ADORWELD.BO's competition here